Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RVMDW
#8415
Revolution Medicines, Inc. Common Stock
2.160
0
+9.09%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+9.09%
Monthly Change
+13.68%
6 month change
+1066.94%
Year Change
+1763.68%
Previous Close
1.980
0
Open
2.160
0
Bid
Ask
Low
2.160
0
High
2.160
0
Volume
1
Markets
US Stock Market
Healthcare
RVMDW
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
168.22 M
185.91 M
186.27 M
186.93 M
193.32 M
198.17 M
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
—
Price to earnings ratio
-0.04
-0.05
-0.01
-0.06
-0.06
-0.16
-0.28
Price to sales ratio
21.35
—
5.64
26.34
22.55
—
—
Price to cash flow ratio
0.04
0.05
0.01
0.07
0.07
0.2
0.35
Price to book ratio
0
0.01
0
0.01
0.01
0.11
0.12
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.09
-0.08
-0.09
-0.1
-0.14
-0.15
-0.48
Return on equity %
-0.1
-0.09
-0.1
-0.13
-0.19
-0.22
-0.65
Return on invested capital %
-286.23
-309.69
—
—
—
96.88
—
Gross margin %
—
—
100
100
100
100
400
Operating margin %
—
—
-18.99 K
-43.4 K
-50.12 K
-43.31 K
-155.81 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
-16.83 K
-40.62 K
-48.52 K
-43.7 K
-149.67 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
14.24
14.2
13.46
11.79
8.05
7.14
40.45
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.78
-0.82
-1.03
-1.18
-1.1
-1.44
-4.75
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
9.29
13.65
11.18
11.33
10.21
10.65
43.37
Net current asset value per share
9.46
13.88
11.35
11.54
10.45
10.91
44.25
Tangible book value per share
8.96
13.08
10.67
9.52
8.07
8.21
36.46
Working capital per share
8.8
12.9
10.5
10.56
9.15
9.39
39.6
Book value per share
9.39
13.5
11.05
9.89
8.44
8.58
37.96
News
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance
LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD)
Janus Henderson Enterprise Fund Q4 2025 Portfolio Review
Immuneering: Strong Buy Despite Decline In Share Price On Atebimetinib Data (NASDAQ:IMRX)
LABU: The Risks And Rewards Of A Leveraged Biotechnology ETF (NYSEARCA:LABU)
Tango Therapeutics: PRMT5 Inhibitor Vopimetostat Approaches Pivotal Testing - Buy (TNGX)
Revolution Medicines, Inc. (RVMD) Q3 2025 Earnings Call Transcript
Revolution Medicines, Inc. (RVMD) Special Call - Slideshow (NASDAQ:RVMD)
Revolution Medicines, Inc. (RVMD) Q4 2024 Earnings Call Transcript